| Literature DB >> 30655687 |
William Jackson1, Emily L Zale2, Stanley J Berman3, Alberto Malacarne1, Amy Lapidow4, Michael E Schatman5,6, Ronald Kulich1,7, Ana-Maria Vranceanu2.
Abstract
PURPOSE: The importance of improved physical function as a primary outcome in the treatment of chronic pain is widely accepted. There have been limited attempts to assess the effects mindfulness skills training (MST) has on objective outcomes in chronic pain care.Entities:
Keywords: activity trackers; chronic pain; mindfulness; outcome measures; physical functioning; systematic review
Year: 2019 PMID: 30655687 PMCID: PMC6322706 DOI: 10.2147/JPR.S172733
Source DB: PubMed Journal: J Pain Res ISSN: 1178-7090 Impact factor: 3.133
Figure 1Flowchart of this systematic review showing the process of search, exclusion of studies, and inclusion of studies for quality assessment and extraction of data.
Characteristics of selected studies
| Study | Design | Quality score | Population | Mean age | Intervention | Sessions and duration | Control condition | n | Summary of functional measures |
|---|---|---|---|---|---|---|---|---|---|
| Astin et al (2003) | RCT | 9/10 | Fibromyalgia | 48 | MBSR + Qigong | 8 sessions 2.5 hours | Education | 128 | 6MWT: no improvements in both groups |
| Brown and Jones (2013) | RCT | 8/10 | Musculoskeletal pain | – | Mindfulness- based pain management | 8 weeks | TAU | 28 | SF-36 (PCS): no improvement |
| Cash et al (2015) | RCT | 8/10 | Fibromyalgia | – | MBSR | 8 weeks | Waitlist | 91 | FIQ (PFS): improvement not significant |
| Esmer et al (2010) | RCT | 8/10 | Failed back surgery syndrome | 55 | MBSR | 8 weeks 1.5–2.5 hours | Waitlist | 25 | RMDQ: significant between groups |
| Fjorback et al (2013) | RCT | 8/10 | Somatization, functional somatic | 40 | MBSR | 8 weeks 3.5 hours | CBT and TAU | 119 | SF-36 (PCS): both groups significantly improved no significant difference between groups |
| Gardner-Nix et al (2014) | RCT | 7/10 | Chronic pain | 52 | MBSR | 12 weeks | Waitlist | 119 | SF-36 v2 (PCS): improvement not significant |
| Goldenberg et al (1994) | RCT | 8/10 | Fibromyalgia | 47 | SR-CBT | 10 weeks 2 hours | Waitlist | 120 | FIQ: significant improvement |
| La Cour and Petersen (2015) | RCT | 8/10 | Chronic pain | 48 | MBSR | 8 weeks 2.5 hours | Waitlist | 109 | SF-36 (PCS): improvement not significant |
| Morone et al (2008) | RCT | 10/10 | Chronic low back pain | 75 | MBSR | 8 weeks 1.5 hours | Waitlist | 37 | SPPB: no significant differences between the two groups SF-36 (PCS): improvement not significant SF-36 (PFS): significant between groups RMDQ: improvement not significant |
| Morone et al (2009) | RCT | 9/10 | Chronic low back pain | 76 | MBSR | 8 weeks 1.5 hours | Education | 35 | RMDQ: improvements in both groups, no statistically significant difference |
| Plews-Ogan et al (2005) | 3-arm RCT | 7/10 | Chronic musculoskeletal pain | 47 | MBSR | 8 weeks 2.5 hours | Massage and TAU | 30 | SF-12 (PCS): no improvements |
| Schmidt et al (2011) | 3-arm RCT | 9/10 | Fibromyalgia | 52 | MBSR | 8 weeks | Active control and waitlist | 177 | FIQ: improvements in the MBSR group, but no significant difference between groups |
| Weissbecker et al (2002) | RCT | 8/10 | Fibromyalgia | 18+ | MBSR | 8 weeks 2.5 hours | Waitlist | 91 | FIQ (PFS): no significant between group difference |
| Wells et al (2014) | RCT | 9/10 | Migraines | 46 | MBSR | 8 weeks | TAU | 19 | MIDAS: significant improvement |
| Zangi et al (2012) | RCT | 8/10 | Inflammatory rheumatic joint disease | 54 | VTP – MBGI | 10 sessions + booster | Routine care | 71 | NRS (of self-care ability): significant treatment effects |
Note: Quality rating was based on predefined 10-point criteria.
Abbreviations: CBT, cognitive behavioral therapy; FIQ, Fibromyalgia Impact Questionnaire; FIQ (PFS), physical functioning scale of FIQ; MBSR, mindfulness-based stress reduction; MIDAS, migraine disability assessment; NRS, 10-point numeric rating scale; RCT, randomized controlled trial; RMDQ, Roland Morris Disability Questionnaire; SF-36 (PCS), physical component scale of SF-36; SF-36 v2 (PCS), physical component scale of SF-36 version 2; SF-36 (PFS), physical functioning scale of SF-36; SPPB, short physical performance battery; SR-CBT, stress reduction cognitive behavioral therapy; TAU, treatment as usual; VTP – MBGI, vitality training programme – mindfulness-based group intervention.
10-Item quality assessment
| A | Sociodemographic and medical data described (eg, age, race, employment, education) |
| B | Process of data collection clearly described (eg, interviews, questionnaires, accelerometer) |
| C | Type of chronic pain described (eg, low back pain, fibromyalgia) |
| D | Results are compared between two or more groups (eg, healthy populations, between patient groups, etc) |
| E | Participation and response rate reported and more than 75% |
| F | Differences between responders/nonresponders are presented when they exist |
| G | Results are described for objective and subjective measures of physical function |
| H | Standard statistics (mean, median, range, SD) are present for the main study variables |
| I | Patients and/or their parents signed an informed consent prior to study participation, and this was explicitly stated in the manuscript |
| J | Selection of participants is adequately described |
Notes: The studies that have met inclusion criteria for this systematic review were assessed for quality using the above criteria. A study that meets criteria for a particular category was given 1 point with 10 points (100%) being the maximum score. This quality assessment was Adapted by permission from Springer Nature Customer Service Centre GmbH: Springer Nature Journal of Neuro-Oncology Vranceanu AM, Merker VL, Park E, Plotkin SR. Quality of life among adult patients with neurofibromatosis 1, neurofibromatosis 2 and schwannomatosis: a systematic review of the literature. J Neurooncol. 2013;114(3):257–262, © 2013.22